Marc D. Schwartz, Ph.D., is a Professor of Oncology, Co-Director of the Cancer Prevention and Control Program and Research Director of the Fisher Center for Hereditary Cancer and Clinical Genomics Research at the Lombardi Comprehensive Cancer Center, where he has been a faculty member since 1995.
Dr. Schwartz received his Ph.D. in Clinical Psychology from the State University of New York at Stony Brook in 1992 and completed a postdoctoral fellowship at the Memorial Sloan Kettering Cancer Center. He has subsequently received additional training in Epidemiology and Genetics.
As a behavioral scientist, Dr. Schwartz is internationally recognized for his research on clinical and population translation of genomic advances, cancer prevention and risk communication. He has been continuously funded by the National Cancer Institute since 1995. This funding has included multiple grants focused on genetic testing for cancer susceptibility, such as studies examining the impact of testing in newly diagnosed breast cancer patients, studies examining innovative approaches to the delivery of genetic counseling and testing and the evaluation of decision support tools for women who have recently received genetic test results.
Dr. Schwartz has published over 130 peer-reviewed articles, commentaries, and chapters in the field of cancer prevention, genetic testing and risk management. As co-Director of the Lombardi Comprehensive Cancer Center’s Cancer Prevention and Control Program, he oversees one of the nation’s top research programs focused on reducing the incidence, morbidity and mortality of cancer. Dr. Schwartz also lectures frequently to graduate and medical students, and mentors postdoctoral fellows and junior faculty.